Preclinical research: Make mouse studies work

Steve Perrin ()
Additional contact information
Steve Perrin: Steve Perrin is chief scientific officer at the ALS Therapy Development Institute in Cambridge, Massachusetts, USA.

Nature, 2014, vol. 507, issue 7493, 423-425

Abstract: More investment to characterize animal models can boost the ability of preclinical work to predict drug effects in humans, says Steve Perrin.

Date: 2014
References: Add references at CitEc
Citations: View citations in EconPapers (6)

Downloads: (external link)
https://www.nature.com/articles/507423a Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:507:y:2014:i:7493:d:10.1038_507423a

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/507423a

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().